Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.96 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | LTA4H | P09960 | 1/20 | 0.67 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.67 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.66 |
| ▸ | DRD2 | P14416 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | ACHE | P22303 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3683452 | 0.98 | SLC6A3 (0.96) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| SCHEMBL11589061 | 0.98 | SIGMAR1 (1.00) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| 1-Phenethylpiperidine SCHEMBL917609 | 0.98 | SIGMAR1 (1.00) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| 1-Phenethylpiperidine SCHEMBL4054824 | 0.98 | SIGMAR1 (1.00) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| Iodide SCHEMBL3691021 | 0.98 | SLC6A3 (0.96) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| SCHEMBL11922748 | 0.98 | SIGMAR1 (1.00) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| Hydrochloric Acid SCHEMBL28216902 | 0.98 | SLC6A3 (0.96) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| 1-Phenethylpiperidine SCHEMBL11507835 | 0.96 | SIGMAR1 (0.96) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| 1-Phenethylpiperidine SCHEMBL11404041 | 0.96 | SIGMAR1 (0.96) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H | |
| 1-Phenethylpiperidine SCHEMBL7524827 | 0.96 | SIGMAR1 (0.96) | SLC6A3SIGMAR1HRH3L3MBTL1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119606059-A | Preparation method of filter element material for enhancing tobacco smoke adsorption | 奥伯风环境科技(南京)有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-112441888-B | Pd-ReOx/CeO2Method for preparing nitrogen-containing aromatic compound by catalyzing lignin ammoniation reaction | 中国科学院大连化学物理研究所 | 2021-10-26 | — | — | CN | claimed |
| CN-112441888-A | Pd-ReOx/CeO2Method for preparing nitrogen-containing aromatic compound by catalyzing lignin ammoniation reaction | 中国科学院大连化学物理研究所 | 2021-03-05 | — | — | CN | claimed |
| US-10836874-B2 | High performance cross-linked triblock cationic functionalized polymer for electrochemical applications, methods of making and methods of using | COLORADO SCHOOL OF MINES (US) | 2020-11-17 | — | — | US | claimed |
| US-20190100633-A1 | HIGH PERFORMANCE CROSS-LINKED TRIBLOCK CATIONIC FUNCTIONALIZED POLYMER FOR ELECTROCHEMICAL APPLICATIONS, METHODS OF MAKING AND METHODS OF USING | UNIVERSITY OF MASSACHUSETTS | 2019-04-04 | — | — | US | claimed |
| EP-2702041-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | Chiesi Farmaceutici S.p.A. (IT) | 2014-03-05 | — | — | EP | claimed |
| US-8604015-B2 | Alkaloid ester and carbamate derivatives and medicinal compositions thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-12-10 | — | — | US | claimed |
| WO-2012146515-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-11-01 | — | — | WO | claimed |
| US-20120276018-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-11-01 | — | — | US | claimed |
| US-20100168490-A1 | METHOD FOR PREPARATION OF AN ALUMINOSILICATE WITH FERRIERITE STRUCTURE FROM GELS CONTAINING TETRAMETHYLAMMONIUM AND BENZYLMETHYLPYRROLIDINE, AND USES THEREOF | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2010-07-01 | — | — | US | claimed |
| EP-2133309-A1 | METHOD FOR PREPARATION OF AN ALUMINOSILICATE WITH FERRIERITE STRUCTURE FROM GELS CONTAINING TETRAMETHYL AMMONIUM AND BENZYLMETHYLPYRROLIDINE, AND USES THEREOF | Consejo Superior De Investigaciones Científicas (ES) | 2009-12-16 | — | — | EP | claimed |
| EP-0483580-A2 | 1-(2-Arylethyl)-pyrrolidine | MERCK PATENT GmbH (DE) | 1992-05-06 | — | — | EP | claimed |
| US-4772602-A | VASODILATION, HYPOTENSIVE | SUNTORY LIMITED (JP) | 1988-09-20 | — | — | US | claimed |
| EP-4622743-A1 | SYNTHESIS OF A HIGH PURITY IZM-8 ZEOLITE OF FER FRAMEWORK TYPE | IFP Energies nouvelles (FR) | 2025-10-01 | — | — | EP | disclosed |
| CN-119606059-A | Preparation method of filter element material for enhancing tobacco smoke adsorption | 奥伯风环境科技(南京)有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119101013-A | Method for synthesizing dithiocarbamic acid ester derivative | 宁夏医科大学 | 2024-12-10 | — | — | CN | disclosed |
| WO-1996025420-A1 | CHIRAL ORGANOMETALLIC COMPOUNDS | ZENECA LIMITED (GB) | 1996-08-22 | — | — | WO | disclosed |
| WO-1995002567-A1 | CATALYTIC ASYMMETRIC REDUCTION OF TRISUBSTITUTED OLEFINS AND ENAMINES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1995-01-26 | — | — | WO | disclosed |
| US-5232978-A | 1-(2-arylethyl)-pyrrolidines | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-08-03 | — | — | US | disclosed |
| EP-0483580-A2 | 1-(2-Arylethyl)-pyrrolidine | MERCK PATENT GmbH (DE) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276018-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHRM3, BCHE, CHRM1 | SLC6A3 4087/4885SIGMAR1 1448/4885HRH3 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.